RNA methylation in mammalian development and cancer

Cell Biol Toxicol. 2021 Dec;37(6):811-831. doi: 10.1007/s10565-021-09627-8. Epub 2021 Jul 17.

Abstract

Similar to epigenetic DNA and histone modifications, epitranscriptomic modifications (RNA modifications) have emerged as crucial regulators in temporal and spatial gene expression during eukaryotic development. To date, over 170 diverse types of chemical modifications have been identified upon RNA nucleobases. Some of these post-synthesized modifications can be reversibly installed, removed, and decoded by their specific cellular components and play critical roles in different biological processes. Accordingly, dysregulation of RNA modification effectors is tightly orchestrated with developmental processes. Here, we particularly focus on three well-studied RNA modifications, including N6-methyladenosine (m6A), 5-methylcytosine (m5C), and N1-methyladenosine (m1A), and summarize recent knowledge of underlying mechanisms and critical roles of these RNA modifications in stem cell fate determination, embryonic development, and cancer progression, providing a better understanding of the whole association between epitranscriptomic regulation and mammalian development.

Keywords: 5-methylcytosine; Cancer progression; Embryonic development; N 1-methyladenosine; N 6-methyladenosine; RNA metabolism; Stem cell fate determination.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adenosine* / metabolism
  • Animals
  • Cell Differentiation
  • Methylation
  • Neoplasms* / genetics
  • RNA / genetics
  • RNA / metabolism

Substances

  • RNA
  • Adenosine